CD19 and systemic sclerosis: To evaluate the presence of CD21lo/neg B cells in the lung parenchyma of SSc-ILD, IHC staining for CD19 and CD21 was performed in a SSc-ILD explant and a patient with chronic post-obstructive pneumonia (Fig. 6).